Form 4: Chemed Corp Director Andrea R. Lindell Acquires 277 Shares of Capital Stock

Director Andrea R. Lindell acquired 277 shares of Chemed Corp capital stock at $579.04 per share on May 19, 2025.

Summary

• On May 19, 2025, Andrea R. Lindell, a director of Chemed Corp, acquired 277 shares of the company's capital stock.
• The acquisition was a direct transaction.
• The price per share was $579.04.
• Following the transaction, Lindell directly owns 6,002 shares of Chemed Corp capital stock.

Sentiment

Score: 6

Explanation: Neutral sentiment. This is a routine disclosure of an insider stock purchase. While insider buying can be seen as a positive signal, it's a single transaction and doesn't necessarily indicate a major shift in the company's outlook.

Positives

• A director's purchase of company stock can be seen as a positive signal, indicating confidence in the company's future prospects.

Industry Context

This is a routine disclosure of insider trading activity. It's important to monitor such filings to understand the sentiment of company insiders regarding the company's prospects.

Comparison to Industry Standards

• Insider trading activity is common across publicly listed companies.
• Monitoring Form 4 filings is a standard practice for investors to gauge insider sentiment.
• Comparing the volume and frequency of insider transactions with peers like Amedisys or LHC Group can provide a broader perspective.

Stakeholder Impact

• The transaction could have a minor positive impact on shareholder sentiment.

Key Dates

Keywords

Chemed Corp, Director, Stock Acquisition, Beneficial Ownership, Form 4, Lindell, Capital Stock